USA - NASDAQ:QIPT - CA74880P1045 - Common Stock
ChartMill assigns a Buy % Consensus number of 80% to QIPT. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-19 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-05-14 | Benchmark | Maintains | Buy -> Buy |
| 2025-05-13 | Canaccord Genuity | Downgrade | Buy -> Hold |
| 2024-08-21 | Benchmark | Maintains | Buy -> Buy |
| 2024-08-16 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-05-20 | Benchmark | Maintains | Buy -> Buy |
| 2024-05-17 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-02-16 | Raymond James | Downgrade | Outperform -> Market Perform |
| 2023-12-20 | Benchmark | Reiterate | Buy -> Buy |
| 2023-05-17 | Benchmark | Reiterate | Buy -> Buy |
| 2023-02-15 | Benchmark | Reiterate | Buy |
| 2023-02-13 | Benchmark | Reiterate | Buy |
| 2021-10-20 | Benchmark | Initiate | Buy |
| 2021-06-02 | Raymond James Financial | Initiate | Outperform |
11 analysts have analysed QIPT and the average price target is 3.72 USD. This implies a price increase of 65.53% is expected in the next year compared to the current price of 2.25.
The consensus rating for QUIPT HOME MEDICAL CORP (QIPT) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering QUIPT HOME MEDICAL CORP (QIPT) is 11.